Mef2c plays oncogenic role in ALL, Acute Myeloid Leukemia (AML), colon adenocarcinoma, Diffuse Large B Cell Lymphoma (DLBCL), and T-cell lymphomas. This evidence concerns the gene MEF2C and colon adenocarcinoma.